Treace Medical Concepts to Engage at Morgan Stanley Conference
![Treace Medical Concepts to Engage at Morgan Stanley Conference](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
Treace Medical Concepts Engages at Healthcare Conference
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a pioneering medical technology company, is set to demonstrate its leadership in the surgical treatment of bunions and related midfoot deformities. The company's flagship product, Lapiplasty, has revolutionized how these conditions are treated, addressing the underlying causes rather than just the symptoms.
Upcoming Fireside Chat at Morgan Stanley Event
John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer of Treace, will participate in a fireside chat at the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference. This event is scheduled to begin at approximately 10:00 am ET.
Webcast Details
A live webcast and replay of this engaging discussion will be accessible on the Company’s investor relations website. This platform will allow investors and stakeholders to follow the conversation and stay informed about the latest developments and strategies employed by the Company.
Commitment to Investor Relations
Treace maintains a valuable resource for investors through its investor relations section on the Company’s website. Treace is committed to sharing critical updates and insights, allowing current and prospective shareholders to remain well-informed about the company’s performance and market strategies.
Importance of Information Posting
Investors are encouraged to routinely check the Treace website for important announcements and information that could impact their investment decisions. Timely information dissemination is a key aspect of the Company's engagement strategy with its investors.
Revolutionizing Surgical Treatment of Bunions
Treace Medical Concepts is dedicated to enhancing the standard of care in surgical management of bunion and other midfoot deformities. Each year, approximately 1.1 million Americans opt for surgery related to bunion deformities, showcasing the need for effective treatment solutions.
Innovative Solutions at Treace
To address bunion conditions comprehensively, Treace has developed the Lapiplasty® 3D Bunion Correction® System. This patented system integrates various instruments, implants, and surgical techniques tailored to correct bunions in three dimensions. The aim is to ensure that the procedure resolves the instability of the affected joint, thereby assisting patients in resuming their active lifestyles swiftly.
Focus on Midfoot Deformities
Additionally, Treace has introduced the Adductoplasty® Midfoot Correction System. This innovative system is designed specifically for the reproducible surgical correction of midfoot deformities. The introduction of SpeedPlate™ Rapid Compression Implants further diversifies the Company’s portfolio, providing an innovative fixation platform that enhances surgical versatility.
Market Expansion Plans
With the advent of these novel technologies, Treace aims to expand its market presence within the foot and ankle sector. By continuing to innovate and enhance its product offerings, Treace seeks to hold a leading position in the medical technology industry dedicated to treating foot-related ailments.
Connect with Treace Medical Concepts
For further information about Treace Medical Concepts and its offerings, interested parties are encouraged to visit their official website. Comprehensive details about their products, company news, and resources for investors are also available. Engaging with Treace on social media platforms such as LinkedIn, X, Facebook, and Instagram enables a broader understanding of their commitment to improving surgical outcomes for patients.
Contact Information
For inquiries, individuals may reach out to Treace Medical Concepts directly through the contact details listed below:
Contacts:
Mark L. Hair
Chief Financial Officer
Email: mhair@treace.net
Phone: (904) 373-5940
Investors:
Vivian Cervantes
Email: IR@treace.net
Frequently Asked Questions
What is Treace Medical Concepts known for?
Treace Medical Concepts specializes in medical technology designed to treat bunions and midfoot deformities, offering advanced surgical solutions.
When will Treace participate in the Morgan Stanley Conference?
The participation is scheduled for a fireside chat occurring at approximately 10:00 am ET.
How can investors access the webcast?
Investors can access the live webcast through the investor relations section of the Treace Medical Concepts website.
What systems has Treace developed for bunion treatment?
Treace has developed the Lapiplasty® 3D Bunion Correction® System and the Adductoplasty® Midfoot Correction System.
How does Treace support its investors?
Treace supports its investors by regularly posting pertinent information on their website and through social media engagement.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Coupon Rate Adjustment Announcement by Nykredit Realkredit A/S
- Man Group PLC's Strategic Stake in Barratt Developments
- 64th IGCA Congress Celebrates Global Garden Retailing
- Growth of Flare Gas Recovery System Market to $6.8 Billion
- Automotive Bushing Market Expected to Exceed $264 Billion
- Microcarrier Market Expected to Reach $2.5 Billion by 2034
- OKX Wallet Enhances DeFi Trading with NovaBits Integration
- Growth of Lithium Cobalt Oxide Cathode Market
- QuantaSing Group to Announce 2024 Financial Results Soon
- Understanding Drawing Rates for Bonds by Realkredit Danmark